Comparison of international blood pressure guidelines

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ewingdo (talk | contribs) at 22:53, 24 March 2024 (Updated NICE guidelines). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Guidelines on the choice of agents and how best to step up treatment for various subgroups have changed over time and differ between countries.

A Comparison of International Guidelines on Goal BP and Initial Drug Therapy for Adults With Hypertension (adapted from JNC 8 guidelines[1])
Guideline Population Goal BP, mmHg Initial drug treatment options
AAFP 2022[2][3] General - Strong Recommendation

General - Weak Recommendation

<140/90


<135/85

Stage 1 >140/90 and low-risk for ASCVD: Lifestyle changes

Stage 1 >140/90 and ASCVD risk factors or failed lifestyle changes: monotherapy with thiazide-type diuretic, ACEI, ARB, or CCB

Stage 2 > 160/100: two from different classes - thiazide-type diuretic, ACEI, ARB, or CCB

KDIGO 2021[4] CKD

with kidney transplant

SBP <120

<130/80

CKD: ACEI or ARB

Kidney transplant: ARB or CCB

NICE 2019[5] General <80 y

General ≥80 y

<140/90

<150/90

<55 y: ACEI, or ARB

≥55 y or black: CCB

ACC/AHA 2017[6] General <130/80 BP > 130/80: Lifestyle changes and monotherapy with thiazide-type diuretic, ACEI, ARB, or CCB

BP >20//10 above target: Lifestyle changes and two from different classes - thiazide-type diuretic, ACEI, ARB, or CCB

JNC 8 2013[1] General ≥60 y

General <60 y

Diabetes

CKD

<150/90

<140/90

<140/90

<140/90

Non-black: thiazide-type diuretic, ACEI, ARB, or CCB

Black: thiazide-type diuretic, or CCB

Diabetes: thiazide-type diuretic, ACEI, ARB, or CCB

CKD: ACEI or ARB

ESH/ESC 2008 General nonelderly

General elderly

General ≥80 y

Diabetes

CKD

CKD + proteinuria

<140/90

<150/90

<150/90

<140/85

<140/90

<130/90

General: beta-blocker, diuretic, CCB, ACEI, or ARB

Diabetes: ACEI, or ARB

CKD: ACEI, or ARB

CHEP 2013 General <80 y

General ≥80 y

Diabetes

CKD

<140/90

<150/90

<130/80

<140/90

General: thiazide-type diuretic, beta-blocker (age, 60 y), ACEI (non-black) or ARB

Diabetes with additional risk : ACEI, or ARB

Diabetes without additional risk : ACEI, ARB, thiazide, or DHPCCB

CKD: ACEI, or ARB

ADA 2013 Diabetes <140/90 ACEI, or ARB
ISHIB Black, lower risk

Target organ damage or CVD risk

<135/85

<130/80

Diuretic or CCB

Abbreviations:

  • AAFP – American Academy of Family Physicians
  • ACC – American College of Cardiology
  • ACEI – angiotensin-converting enzyme inhibitor
  • ADA – American Diabetes Association
  • AHA – American Heart Association
  • ARB – angiotensin receptor blocker
  • CCB – calcium channel blocker
  • CHEP – Canadian Hypertension Education Program
  • CKD – chronic kidney disease
  • CVD – cardiovascular disease
  • DHPCCB – dihydropyridine calcium channel blocker
  • ESC – European Society of Cardiology
  • ESH – European Society of Hypertension
  • ISHIB – International Society for Hypertension in Blacks
  • JNC – Joint National Committee
  • KDIGO – Kidney Disease: Improving Global Outcome
  • NICE – National Institute for Health and Clinical Excellence (United Kingdom)


References

  1. ^ a b James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, DT.; Lefevre, ML.; Mackenzie, TD.; Ogedegbe, Olugbenga; Smith, Sidney C.; Svetkey, Laura P.; Taler, Sandra J.; Townsend, Raymond R.; Wright, Jackson T.; Narva, Andrew S.; Ortiz, Eduardo (Dec 2013). "2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.
  2. ^ Coles, Sarah; Fisher, Lynn; Lin, Kenneth W.; Lyon, Corey; Vosooney, Alexis A.; Bird, Melanie D. (December 2022). "Blood Pressure Targets in Adults With Hypertension: A Clinical Practice Guideline From the AAFP". American Family Physician. 106 (6): Online. ISSN 1532-0650. PMID 36521481.
  3. ^ Clarke, S. Lindsey (October 2023). "Hypertension in Adults: Initial Evaluation and Management". American Family Physician. 108 (4): 352–359. ISSN 1532-0650. PMID 37843942.
  4. ^ Cheung, Alfred K.; Chang, Tara I.; Cushman, William C.; Furth, Susan L.; Hou, Fan Fan; Ix, Joachim H.; Knoll, Gregory A.; Muntner, Paul; Pecoits-Filho, Roberto; Sarnak, Mark J.; Tobe, Sheldon W.; Tomson, Charles R.V.; Mann, Johannes F.E. (2021-03). "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease". Kidney International. 99 (3): S1–S87. doi:10.1016/j.kint.2020.11.003. {{cite journal}}: Check date values in: |date= (help)
  5. ^ "Overview | Hypertension in adults: diagnosis and management | Guidance | NICE". www.nice.org.uk. 2019-08-28. Retrieved 2024-03-24.
  6. ^ Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.; Casey, Donald E.; Collins, Karen J.; Dennison Himmelfarb, Cheryl; DePalma, Sondra M.; Gidding, Samuel; Jamerson, Kenneth A.; Jones, Daniel W.; MacLaughlin, Eric J.; Muntner, Paul; Ovbiagele, Bruce; Smith, Sidney C.; Spencer, Crystal C. (2018-05-15). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults". Journal of the American College of Cardiology. 71 (19): e127–e248. doi:10.1016/j.jacc.2017.11.006.